Search Results 6591-6600 of 20694 for preventive%20mastectomy

  1. Pelvic exenteration: Radical but positive for carefully selected patients with pelvic cancer - Mayo Clinic

    ... prevention. "With these efforts, we believe there is a safe way to minimize complications and improve overall patient outcomes," says Dr. Kumar. Criteria ...

  2. Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab - Mayo Clinic

    The purpose of this study is to compare the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer ...

  3. Deb Balzer | Mayo Clinic News Network - Page 3 of 72

    By Deb Balzer • February 20, 2025. Mayo Clinic Minute: What high triglycerides mean and why it matters to your heart. You may be familiar with high-density ...

  4. Laryngeal Diadochokinetic Interpretation Changes in Patients Status Post Injection Medialization Procedures for Vocal Fold Paresis/Paralysis - Mayo Clinic

    Jacksonville, Florida: 20-005492. About this study. The purpose of this study is to determine if there is an acoustic change in voices during L-DDK ...

  5. Head and neck cancers - Doctors and departments - Mayo Clinic

    This designation recognizes the institution's scientific excellence and multidisciplinary resources focused on cancer prevention, diagnosis and treatment.

  6. A Study to Create an Hereditary Hemorrhagic Telangiectasia and Gastric Anal Vascular Ecstasia Biorepository - Mayo Clinic

    Rochester, Minnesota: 20-012134. About this study. The purpose of this study is to develop a repository of blood and tissue from patients with epistaxis and ...

  7. A Study to Assess the Diagnosis, Gender Prevalence, Management and Outcomes of Cough Hypersensitivity Syndrome - Mayo Clinic

    Rochester, Minnesota: 20-001443. About this study. The purpose of this study is to identify the burden of Cough Hypersensitivity Syndrome (CHS) diagnosis made ...

  8. Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors - Mayo Clinic

    ... prevention may resume a low dose (i.e., maximum 100 mg QD) of aspirin if platelet counts are stable (>= 50,000/mm^3) through 6 weeks of navitoclax ...

  9. A Study Evaluating the Safety and Effectiveness of BIV201 and Standard of Care Compared to Standard of Care to Reduce the Recurrence of Ascites and Complications in Patients with Refractory Ascites Secondary to Decompensated Liver Cirrhosis - Mayo Clinic

    Rochester, Minnesota: 20-013403; Jacksonville, Florida: 20-013403. NCT ID: NCT04112199. Sponsor Protocol Number: CIT-002. About this study. The purpose of this ...

  10. A Study Evaluating Deep Brain Stimulation for Treating Parkinson's Patients with Insomnia - Mayo Clinic

    Patient will have been symptomatic with Parkinsonism for 7-20 years. The patient must have severe insomnia based on ISI score,. Exclusionary Criteria ...